Cargando…
CAR‐NK cells: the next wave of cellular therapy for cancer
T cells engineered to express chimeric antigen receptors (CARs) have revolutionised the field of cellular therapy for cancer. Despite its success, this strategy has some recognised limitations and toxicities. Hence, there is growing interest in developing novel cellular therapies based on non‐αβ T‐c...
Autores principales: | Daher, May, Melo Garcia, Luciana, Li, Ye, Rezvani, Katayoun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8080297/ https://www.ncbi.nlm.nih.gov/pubmed/33959279 http://dx.doi.org/10.1002/cti2.1274 |
Ejemplares similares
-
Engineering the next generation of CAR-NK immunotherapies
por: Biederstädt, Alexander, et al.
Publicado: (2021) -
CAR T cells take centre stage
por: Beavis, Paul A, et al.
Publicado: (2019) -
A new integrable model of long wave–short wave interaction and linear stability spectra
por: Caso-Huerta, Marcos, et al.
Publicado: (2021) -
CAR-NK cell therapy for glioblastoma: what to do next?
por: Xiong, Qi, et al.
Publicado: (2023) -
Regulation of the human NK cell compartment by pathogens and vaccines
por: Goodier, Martin R, et al.
Publicado: (2021)